Loading…
Nanobiotix S.A. is projected to rise to $54.71 by 2027, a +37% move from its current price of $40.07. NBTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $38.67 | $40.10 | $41.57 | +0.07% |
| Jul 14 | $38.12 | $40.12 | $42.23 | +0.13% |
| Jul 15 | $37.71 | $40.15 | $42.74 | +0.20% |
| Jul 16 | $37.37 | $40.17 | $43.19 | +0.26% |
| Jul 17 | $37.08 | $40.20 | $43.59 | +0.33% |
| Jul 18 | $36.82 | $40.23 | $43.95 | +0.39% |
| Jul 19 | $36.58 | $40.25 | $44.29 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.58 | $40.25 | $44.29 | +0.46% |
| Week 2 | $35.32 | $40.44 | $46.30 | +0.92% |
| Week 3 | $34.42 | $40.62 | $47.94 | +1.38% |
| Week 4 | $33.70 | $40.81 | $49.41 | +1.84% |
| Week 5 | $33.10 | $41.00 | $50.77 | +2.31% |
| Week 6 | $32.58 | $41.18 | $52.06 | +2.78% |
| Week 7 | $32.12 | $41.37 | $53.29 | +3.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nanobiotix S.A. operates as a clinical-stage biotechnology company focused on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.
The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand.
Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Nanobiotix S.A. - ADSs trade under the symbol NBTX. The current price is $41.10, and the market cap is $1.95B. It ranks 5475.
Near-term forecast for 2026 shows an average price of $41.10 with a neutral sentiment; the min and max for 2026 are $19.97 and $59.17, respectively, and the ROI is 0.
From 2027 onward, the forecast turns bullish, with 2027 avg $54.95, 2028 avg $62.44, 2029 avg $71.22, and 2030 avg $84.00, with respective ROIs of 33.7, 51.9, 73.3, and 104.4.
A major floor 27.6% below — a decisive break under it would weaken the trend.
The nearest floor, 16.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 37.4% above — clearing it would confirm fresh momentum.
Key NBTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NBTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $39.54 | Buy | $39.26 | Buy |
| MA 10 | $38.53 | Buy | $38.58 | Buy |
| MA 20 | $37.11 | Buy | $38.01 | Buy |
| MA 50 | $39.39 | Buy | $37.37 | Buy |
| MA 100 | $35.35 | Buy | $34.60 | Buy |
| MA 200 | $28.43 | Buy | $28.72 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.57 | Neutral |
| Stoch RSI (14) | 80.86 | Sell |
| CCI (20) | 120.08 | Buy |
| Williams %R (14) | -15.26 | Info |
| MACD (12,26,9) | 0.50 | Buy |
| ROC (12) | 9.48 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 84.74 | Sell |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | 2.14 | Buy |
| Ultimate (7,14,28) | 60.50 | Neutral |
| Momentum (10) | 5.64 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 39.46 | Buy |
| ADX (14) | 11.18 | Neutral |
| ATR (14) | 1.26 | Info |
The 30-day technical picture is bullish with RSI(14) 60, and the stock trading above the SMA50 of $38.93 and above the SMA200 of $27.88. It has a defined near-term resistance at $41.10 and support at $33.55. The 30-day price range runs from $31.91 to $52.94, reflecting momentum over the period. The annualized volatility is 70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.97 | $40.07 | $58.22 | 0% | Neutral | |
| $42.25 | $54.71 | $75.70 | +37% | Bullish | |
| $46.47 | $62.52 | $90.65 | +56% | Bullish | |
| $52.25 | $72.60 | $109.14 | +81% | Bullish | |
| $58.70 | $83.92 | $130.06 | +109% | Bullish | |
| $68.11 | $99.95 | $159.02 | +149% | Bullish | |
| $91.02 | $136.90 | $222.99 | +242% | Bullish | |
| $104.98 | $161.61 | $268.88 | +303% | Bullish | |
| $113.26 | $178.27 | $302.42 | +345% | Bullish | |
| $118.93 | $191.24 | $330.30 | +377% | Bullish | |
| $209.30 | $371.56 | $691.50 | +827% | Bullish | |
| $313.50 | $665.35 | $1,378.33 | +15.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.97 | $40.07 | $50.01 | +0.00% |
| August 2026 | $35.98 | $42.83 | $52.62 | +6.89% |
| September 2026 | $35.39 | $42.53 | $53.02 | -0.70% |
| October 2026 | $36.13 | $43.77 | $55.24 | +2.93% |
| November 2026 | $37.47 | $45.71 | $58.27 | +4.42% |
| December 2026 | $36.86 | $45.25 | $58.22 | -1.01% |
Click any year to see its month-by-month NBTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NBTX is projected to trade between $19.97 and $58.22, averaging $40.07 — a potential gain of 0% from today's $40.07. A consolidation phase looks the most probable path here.
Nanobiotix S.A.'s 2027 outlook centres on $54.71, within a $42.25 to $75.70 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2028, NBTX could reach as high as $90.65, with a base case around $62.52 and support toward $46.47 — roughly +56% from $40.07. Buyers look set to stay in control over this stretch.
Expect NBTX to range from $52.25 to $109.14 through 2029. The $72.60 average target implies a +81% move from current prices. That is up +16% on the projected 2028 average. Momentum favours further upside here.
The NBTX price prediction for 2030 points to an average of $83.92 (low $58.70, high $130.06) — a potential gain of +109% on today's $40.07. Buyers look set to stay in control over this stretch.
In 2031, NBTX is projected to trade between $68.11 and $159.02, averaging $99.95 — a potential gain of +149% from today's $40.07. That is up +19% on the projected 2030 average. Momentum favours further upside here.
Nanobiotix S.A.'s 2032 outlook centres on $136.90, within a $91.02 to $222.99 range. That is up +37% on the projected 2031 average. That marks a +242% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, NBTX could reach as high as $268.88, with a base case around $161.61 and support toward $104.98 — roughly +303% from $40.07. Momentum favours further upside here.
Expect NBTX to range from $113.26 to $302.42 through 2034. The $178.27 average target implies a +345% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The NBTX price prediction for 2035 points to an average of $191.24 (low $118.93, high $330.30) — a potential gain of +377% on today's $40.07. Momentum favours further upside here.
In 2040, NBTX is projected to trade between $209.30 and $691.50, averaging $371.56 — a potential gain of +827% from today's $40.07. That is up +94% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Nanobiotix S.A.'s 2050 outlook centres on $665.35, within a $313.50 to $1,378.33 range. That is up +79% on the projected 2040 average. That marks a +15.6x change versus current levels. Momentum favours further upside here.
Investing $1,000 in NBTX today (≈ 24.956326 NBTX) could be worth
$16,604.71
+$15,604.71 (+1560%) by 2050 · US Dollar
Based on the average projected NBTX price of $665.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NBTXwould be worth at today's price.
$1,000 invested in NBTX on Jul 10, 2025 (≈ 191.204588 NBTX) would be worth
$7,661.57
+$6,661.57 (+666.2%) today · 7.66× · US Dollar
Based on a NBTX entry price of $5.23 vs. today's $40.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.4 | $1,043.49 | +4.3% |
| 1 month ago | $33.55 | $1,194.34 | +19.4% |
| 3 months ago | $30.34 | $1,320.7 | +32.1% |
| 6 months ago | $20.07 | $1,996.51 | +99.7% |
| 1 year ago | $5.23 | $7,661.57 | +666.2% |
| All time (5.0y) ago | $14.01 | $2,860.1 | +186.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NBTX forecast.
Our base-case forecast reaches $80.00 around 2030.
Implied market cap at $80.00: $4.06B
The multi-year forecast shows a path of higher values through the late 2020s and beyond. In 2026 the average price is $41.10, rising to $54.95 in 2027, $62.44 in 2028, and $71.22 in 2029, with ROIs of 0, 33.7, 51.9, and 73.3 respectively. By 2030 the average price is $84.00 with an ROI of 104.4.
From 2031 to 2035 the forecast shows continued upside: $102.59 (149.6), $138.50 (237), $162.04 (294.3), $175.61 (327.3), and $185.54 (351.4). Further out, 2040 shows $366.73 (792.3), and 2050 shows $638.76 (1454.2). These figures are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
2030 avg $84.00, min $57.84, max $132.27, ROI 104.4, sentiment BULLISH.
From 2027 onward the forecast shows bullish sentiment with 2027 avg $54.95, 2028 avg $62.44, 2029 avg $71.22, and 2030 avg $84.00.
Yes. The forecast max prices show $108.65 in 2029 and $132.27 in 2030.
Sentiment BULLISH; RSI14 60; SMA50 $38.93; SMA200 $27.88; support $33.55; resistance $41.10; 30-day range low $31.91, high $52.94; annualized volatility 70.
Current price $41.10; market cap $1.95B; rank 5475.
Nanobiotix S.A. Community Discussion
0Share your Nanobiotix S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.